BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15314485)

  • 1. Systemic lupus erythematosus trials: successes and issues.
    Ginzler EM; Moldovan I
    Curr Opin Rheumatol; 2004 Sep; 16(5):499-504. PubMed ID: 15314485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus--2005 annus mirabilis?
    Isenberg D; Rahman A
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):145-52. PubMed ID: 16932674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic agents for systemic lupus erythematosus.
    Gescuk BD; Davis JC
    Curr Opin Rheumatol; 2002 Sep; 14(5):515-21. PubMed ID: 12192247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lupus therapy on the move : The direction is right!].
    Fischer-Betz R; Aringer M
    Z Rheumatol; 2015 Apr; 74(3):182. PubMed ID: 25854150
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.
    Fattah Z; Isenberg DA
    Expert Opin Biol Ther; 2014 Mar; 14(3):311-26. PubMed ID: 24387632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapies in systemic lupus erythematosus.
    Bernal CB; Zamora LD; Navarra SV
    Int J Rheum Dis; 2015 Feb; 18(2):146-53. PubMed ID: 25884458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.
    Trevisani VF; Castro AA; Neves Neto JF; Atallah AN
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002265. PubMed ID: 16625558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we treat systemic lupus erythematosus and other autoimmune diseases without oral steroids?
    Enriquez Merayo E; Sciascia S; Roccatello D; Cuadrado MJ
    Expert Rev Clin Immunol; 2018 Nov; 14(11):877-879. PubMed ID: 30328733
    [No Abstract]   [Full Text] [Related]  

  • 10. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review.
    Peterknecht E; Keasey MP; Beresford MW
    Lupus; 2018 Nov; 27(13):2135-2145. PubMed ID: 30336753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapies in systemic lupus erythematosus: successes, failures and future.
    Hahn BH
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i64-i66. PubMed ID: 21339222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial design in systemic lupus erythematosus.
    Dall'Era M; Wofsy D
    Curr Opin Rheumatol; 2006 Sep; 18(5):476-80. PubMed ID: 16896285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus - an update.
    Drug and Therapeutics Bulletin
    Drug Ther Bull; 2011 Jul; 49(7):81-4. PubMed ID: 21752833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for juvenile-onset systemic lupus erythematosus.
    Carreño L; López-Longo FJ; González CM; Monteagudo I
    Paediatr Drugs; 2002; 4(4):241-56. PubMed ID: 11960513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of lupus erythematosus: recent insights.
    Wallace DJ
    Curr Opin Rheumatol; 2002 May; 14(3):212-9. PubMed ID: 11981315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?
    Schiffenbauer J; Simon LS
    Lupus; 2004; 13(5):398-405. PubMed ID: 15230299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials and tribulations in systemic lupus erythematosus.
    Wofsky D
    Bull NYU Hosp Jt Dis; 2010; 68(3):175-8. PubMed ID: 20969548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.